T
CRL icon

TOBAM’s Charles River Laboratories CRL Stock Holding History

TOBAM’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-273
Closed -$54K – 380
2023
Q3 		$54K Sell
273
-215
-44% -$44.1K ﹤0.01% 328
2023
Q2 		$103K Buy
+488
New +$97.1K 0.01% 306
2023
Q1 		– Sell
-447
Closed -$97K – 378
2022
Q4 		$97K Buy
447
+300
+204% +$65.5K 0.01% 302
2022
Q3 		$29K Sell
147
-104
-41% -$22.5K ﹤0.01% 406
2022
Q2 		$54K Hold
251
– – ﹤0.01% 373
2022
Q1 		$71K Buy
+251
New +$77.4K ﹤0.01% 345

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

TOBAM's CRL Position: Q4 2023 in Review

TOBAM sold out of Charles River Laboratories (CRL) in Q4 2023, closing a stake of 273 shares — an estimated $54K sold.

TOBAM first reported a position in CRL in Q1 2022 and held it in 6 quarters. The position peaked at $103K in Q2 2023. 634 funds tracked by Wall St. Rank hold CRL as of Q4 2023.

  • TOBAM reported no remaining Charles River Laboratories position as of Q4 2023 after selling out during the quarter.
  • TOBAM sold 273 Charles River Laboratories shares in Q4 2023, an estimated $54K.
  • TOBAM first reported a position in Charles River Laboratories in Q1 2022 and held it in 6 quarters.
  • TOBAM's Charles River Laboratories position peaked at $103K in Q2 2023.
  • 634 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2023.

Based on TOBAM's 13F filing for Q4 2023, filed 26 Jan 2024.